@DrHeatherParry @UntameableLight @MichaelRosenYes @MrsNickyClark From analysis of real cases in Spring 2020 approx 50% of patients placed on life support for COVID died. Over time (Sept 2020) this reduced to 40% https://t.co/r9in0sGJMs
RT @iwashyna: On-ECMO mortality here looks just broadly like contemporaneous outcomes as shown by @RyanPBarbaro https://t.co/MiBsaHMoVB h…
RT @iwashyna: On-ECMO mortality here looks just broadly like contemporaneous outcomes as shown by @RyanPBarbaro https://t.co/MiBsaHMoVB h…
RT @iwashyna: On-ECMO mortality here looks just broadly like contemporaneous outcomes as shown by @RyanPBarbaro https://t.co/MiBsaHMoVB h…
RT @iwashyna: On-ECMO mortality here looks just broadly like contemporaneous outcomes as shown by @RyanPBarbaro https://t.co/MiBsaHMoVB h…
On-ECMO mortality here looks just broadly like contemporaneous outcomes as shown by @RyanPBarbaro https://t.co/MiBsaHMoVB https://t.co/YmvdiRs8Y2
@9FD900cxqj6NbAs @QuickToshi COVID-19のECMO導入後90日以内の経過で、こちらは全文読めます。 https://t.co/zlrG60p1SW
@A_F_Hegazy @WHaddaraMed @docpgb @critical367 @arntfield @kwadwo777 Is it fair to say it's "experimental"? The outcomes of COVID ARDS on ECMO don't seem that much different than non-COVID ARDS on ECMO based on publication data at least https://t.co/8MB6Bw
@DrToddLee @WHaddaraMed @docpgb @critical367 @arntfield @kwadwo777 https://t.co/8MB6Bwvn72 67 (6%) remained hospitalised, 311 (30%) were discharged home or to an acute rehabilitation centre, 101 (10%) were discharged to a long-term acute care centre or un
@scottmartinMD The nation wide survival rate in patient with COVID and ECMO is just over 50%. I would take a 1 in 2 chance of survival given that most cannulations are done in younger patients. https://t.co/rK1TuGWUh6
RT @ErinCarlton: Congrats @RyanPBarbaro! #PedsICU @MottPICU https://t.co/FQuN2ylasQ
RT @ErinCarlton: @RyanPBarbaro @MottPICU Be sure to check out his great @TheLancet article! @RyanPBarbaro @MottPICU #PedsICU https://t.co…
RT @ErinCarlton: Congrats @RyanPBarbaro! #PedsICU @MottPICU https://t.co/FQuN2ylasQ
RT @iwashyna: Hey, look, it's @RyanPBarbaro in @nytimes thoughtful article on ECMO (referencing his great @TheLancet article with @ELSOOrg…
RT @iwashyna: Hey, look, it's @RyanPBarbaro in @nytimes thoughtful article on ECMO (referencing his great @TheLancet article with @ELSOOrg…
@RyanPBarbaro @MottPICU Be sure to check out his great @TheLancet article! @RyanPBarbaro @MottPICU #PedsICU https://t.co/sn5bEXx0OH https://t.co/PQyzbzIW3G
RT @iwashyna: Hey, look, it's @RyanPBarbaro in @nytimes thoughtful article on ECMO (referencing his great @TheLancet article with @ELSOOrg…
Hey, look, it's @RyanPBarbaro in @nytimes thoughtful article on ECMO (referencing his great @TheLancet article with @ELSOOrg https://t.co/qFBoiZQU50) https://t.co/RsF1tABEmn @sherifink is asking really good questions about our care https://t.co/Oq4FRyKab
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @jrdelbrio: Repaso de lo más destacable sobre #ECMO durante el último año. @FOAMecmo impecable e infatigable, como siempre. @ECMOHUVH @…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
Interesting reading for takes on ARDS treatment among others
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @iceman_ex: Great thread.
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @jrdelbrio: Repaso de lo más destacable sobre #ECMO durante el último año. @FOAMecmo impecable e infatigable, como siempre. @ECMOHUVH @…
4/@doctorbrijpatel:#ECMO en #COVID19:Cohorte multicéntrico internacional (1035 Pts) 6% hospitalizados 5 meses después de iniciado ECMO 30% egresados a casa 27% a centros de cuidados crónicos u otro hospital 💥Mortalidad 37.4% a 90 días #ATS2021 👉 https:/
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @jrdelbrio: Repaso de lo más destacable sobre #ECMO durante el último año. @FOAMecmo impecable e infatigable, como siempre. @ECMOHUVH @…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @iceman_ex: Great thread.
Great thread.
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
RT @FOAMecmo: Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/…
Year in Review on #ECMO by @doctorbrijpatel 1⃣Early ⬇️ PaCO2 at initiation = ⬆️ neuro-injuries in resp failure https://t.co/8Lfhc4JMhH replies https://t.co/0vOkFlWnYG + https://t.co/isKWpv8sve 2⃣ECMO in #COVID19 analysis of @ELSOOrg registry @TheLancet h
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
RT @drbulentpolat: ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fo…
ECMO (ExtraCorporeal Membran Oxygenation), vücut dışında kanı oksijenlendirerek akciğerlerin ve gerektiğinde de pompa fonksiyonuyla kalbin görevini üstlenen bir yaşam desteği cihazıdır. COVID’in ağır hastalarında hayat kurtarıcı olabiliyor.
Kanın dışarıda oksijenlendirilmesi (EKMO) Ventilasyon yerine benden başkaları da düşünmüş tabii ki : )) "ECMO alan COVID-19 hastalarında ECMO'dan 90 gün sonra tahmini mortalite hem de son ölüm veya taburculuk eğilimi olanlarda mortalite% 40'tan azdı." h
#ECMO in #COVID19 respiratory failure? -> follow #ARDS management algorithm -> evidence increasing... lot left to learn! Brodie D @ctsnetorg @asaiojournal webinar; read 📃@RyanPBarbaro https://t.co/CTJJFRWKsf 📃@EuroELSO https://t.co/iPXh8iewk7 📃@EcmoD
@sweidanmd @leticiakawano @f_g_zampieri @azevedo_lcp @PauloNassar1 @israelmaia16 @virenkaul @GallodeMoraesMD @FlaviaSepsis @laxswamy Curious what data you’re referring to re 28d mortality. The original ? is complex, but largest COVID ECMO study to date (ht
~60% de chance de sobreviver depois de ir pra ECMO. Em 24h da pra saber se o paciente está respondendo e deve continuar no hospital, ou é melhor desligar o aparelho. #PauloGustavo @PauloGustavo31 https://t.co/LT3tT69H9W
RT @dokter_onkologi: #ECMO (Extracorporeal Membrane Oxygenation). Last-Resort Life Support Option Helped Majority of Critically Ill #COVID1…
RT @dokter_onkologi: #ECMO (Extracorporeal Membrane Oxygenation). Last-Resort Life Support Option Helped Majority of Critically Ill #COVID1…
RT @AnestesiaH12O: @Ramifentanilo En este estudio de cohortes de The Lancet el intervalo de días para ECMO estaba entre 2 y 6.5 (mediana de…
RT @AnestesiaH12O: @Ramifentanilo En este estudio de cohortes de The Lancet el intervalo de días para ECMO estaba entre 2 y 6.5 (mediana de…
RT @AnestesiaH12O: @Ramifentanilo En este estudio de cohortes de The Lancet el intervalo de días para ECMO estaba entre 2 y 6.5 (mediana de…
@Ramifentanilo En este estudio de cohortes de The Lancet el intervalo de días para ECMO estaba entre 2 y 6.5 (mediana de 4) con una FiO2 de 100% entre 0.9 y 1.1 días y PAFI < 95 en cualquier caso. https://t.co/IHMsEXX6tN
@NidaQadirMD @ELSOOrg @SCCM @ATSCritCare @accpchest I'm sure you saw this already, but it was 70% in the Lancet study! https://t.co/KlAClfeGDK
@maculu @nickmmark Many have! In this study of over 1000 patients on ECMO for COVID, by the end of the study, 30% were home, 37% sadly died, and the rest were somewhere in between. https://t.co/KlAClfeGDK
RT @ELSOOrg: PS Full results of analysis of the ELSO Registry data to characterize epidemiology, hospital course, risk factors for mortalit…
RT @ELSOOrg: PS Full results of analysis of the ELSO Registry data to characterize epidemiology, hospital course, risk factors for mortalit…
RT @ELSOOrg: PS Full results of analysis of the ELSO Registry data to characterize epidemiology, hospital course, risk factors for mortalit…
I never thought id hear a whole section about #ECMO on @BBCNews, something i worked on whilst at @CARIMMaastricht but more for #cardiogenicshock not #COVID19! For those interested, here are a couple of links https://t.co/AwYKXs9eWH https://t.co/Bcl9dGlP
PS Full results of analysis of the ELSO Registry data to characterize epidemiology, hospital course, risk factors for mortality, outcomes of #ECLS in pts with lab confirmed #SARSCoV2 at https://t.co/UFHjDzLKRN All open access #COVIDFOAM #FOAMcc #COVID19 #F
RT @AvishaySpitzer: @PicturesZohar @RackMada יש בערך 40% תמותה. https://t.co/13OUFEEVqB
@PicturesZohar @RackMada יש בערך 40% תמותה. https://t.co/13OUFEEVqB
.@RyanPBarbaro showed @TheLancet that initial pessimism about role of #ECMO in #COVID19 was wrong: ECMO outcomes for #COVID19 were quite similar to those for other causes of respiratory failure--full ICU support saves COVID lives https://t.co/5GCg69MPrL
@Conralexx @Melhart1151 @FlorianSchwab Hier die Originalstudie mit allen Details https://t.co/QJfBruprnE
Contribuição importantíssima de nossa equipe de ECMO do Hospital de Clínicas de Porto Alegre no LANCET. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry https: